Needle-free IV Connectors Market

Needle-free IV Connectors Market Outlook (2023 to 2033)

The global needle-free IV connectors market is valued at US$ 1.26 billion in 2023 and is projected to reach US$ 2.98 billion by the end of 2033. Global sales of needle-free IV connectors are expected to increase at a high-value CAGR of 9% during the next 10 years.

Needless devices that link administration sets, syringes, and IV catheters are known as needle-free IV connectors. To safeguard the hubs in vascular access systems, these connectors are commonly utilized in hospitals for the intravenous delivery of various fluids and liquids.

Systems based on needle-free technology are particularly beneficial in lowering the danger of bacterial contamination and also contribute to better patient outcomes. The need for needle-free IV connectors is rising due to the increasing cases of chronic illnesses, the rapidly growing rate of the ageing population, and the rising hospitalization rates around the world.

Needle-free IV connectors are segmented into positive fluid displacement connectors, negative fluid displacement connectors, and neutral fluid displacement connectors. Global sales of positive fluid displacement connectors are expected to increase at a CAGR of 9.5% from 2023 to 2033. To avoid a blood blockage, positive fluid displacement pumps a small quantity of liquid into the catheter's tip. Low cost and the ability to reduce catheter occlusions are boosting the demand for positive fluid displacement connectors.

Rising adoption of home healthcare and the increasing number of cases related to contagious diseases are driving the growth of the needle-free IV connectors market. Several companies in the needle-free IV connectors market are focusing on developing advanced needleless connectors.

Report Attributes	Details
Needle-free IV Connectors Market Size (2023E)	US$ 1.26 Billion
Forecasted Market Value (2033F)	US$ 2.98 Billion
Global Market Growth Rate (2023 to 2033)	9% CAGR
China Market Growth Rate (2023 to 2033)	12% CAGR
Japan Market Growth Rate (2023 to 2033)	6% CAGR
Germany Market Growth Rate (2023 to 2033)	7% CAGR
Canada Market Growth Rate (2023 to 2033)	7.5% CAGR
Key Companies Profiled	B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company CareFusion Corporation ICU Medical, Inc. Nexus Medical LLC RyMed Technologies, LLC Vygon SA

What Trends are Generating Opportunities in the Needle-free IV Connectors Market?

“Rising Cases of Cardiovascular Disorders across the World”

Rising prevalence of cardiovascular disorders, advancements in drug delivery systems, and growing adoption of minimally-invasive procedures are boosting the demand for needleless devices.

• In August 2021, Boehringer Ingelheim GmbH released a press statement describing heart failure as a chronic, incapacitating cardio-renal-metabolic condition that affects more than 60 million individuals globally.
• More than 700 million individuals around the world are living with untreated hypertension, according to the World Health Organization (WHO) 2021 report. Additionally, hypertension sharply raises the risk of renal, heart, and brain disorders, according to the same source.

As the prevalence of heart failure continues to rise, new therapeutic options are desperately needed. Thus, the demand for needle-free injectors & IV connectors is expected to rise rapidly.

“Increasing Risk of Bloodstream Infections in Healthcare Facilities”

In hospitals and other healthcare facilities, improper use of needles and syringes can result in various infections, disorders, or even fatalities. The market for needle-free IV connectors is anticipated to develop due to the rise in blood-borne illnesses such as hepatitis B and C and the deaths that result from improper use of needles. The market for needle-free IV connectors is expected to increase rapidly during the forecast period due to increasing demand to prevent needle-stick injuries.

• Around 1 million deaths occur globally due to the improper usage of needles & syringes, as per WHO estimates.

“Rising Worldwide Prevalence of Diabetes & Cancer”

Innovative approaches for providing different medications to patients without puncturing their skin with a traditional needle include needle-free injection systems. The demand for needle-free drug delivery systems is being driven by several factors, including the increasing incidence of chronic diseases such as diabetes and cancer, lifestyle disorders, and the rising preference for self-administer medications. Several chronic diseases have become more common over the past decade, and many of them now necessitate protracted hospital admissions.

• Globally, 19.3 million new cases of cancer were reported in 2020, and 30.2 million new cases are anticipated by 2040, according to GLOBOCAN.
• The age-adjusted comparative prevalence of diabetes worldwide is predicted to be 9.8%, 10.8%, and 11.2%, respectively, for the years 2021, 2030, and 2045, according to the International Diabetes Federation (IDF) Diabetes Atlas 2021 report.

With the rising cases of diabetics and the benefits these products provide over more traditional insulin delivery methods such as pens, pumps, and needles, the demand for needleless injections is expected to increase rapidly.

“Need to Lessen Spread of Infectious Diseases”

Most infections acquired in hospitals are brought on by microorganisms, which proliferate swiftly within the body. In hospitals, infections proliferate more rapidly than chronic infections due to the weak immune systems of the patients and the unsanitary environment. Infectious diseases are more dangerous to healthcare systems, to overcome such situations several healthcare organizations are investing in R&D activities to develop advanced needleless injections and connectors.

Acute care needleless connectors are crucial medical tools that attach to the tip of vascular catheters to allow access to the catheter for aspiration and infusion. The demand for acute care needleless connectors is increasing due to the rising rate of emergency hospital visits.

Nearly 18,416 surgical site infections were reported in the United States in 2020, according to the Centers for Disease Control and Prevention's Healthcare Associated Infection Progress Report 2020.

• In addition, it said that 2,173 of these infections happened during hip arthroplasty and 6,094 occurred during colon surgeries. Demand for needless connectors (NLCs) and injections is increasing due to the high likelihood of surgical site infections.

Which Challenges are Present Before Manufacturers of Needle-free IV Connectors?

“Strict Product Approval Policies”

Product recalls due to defectiveness, inconsistent component quality, and a lack of product handling expertise are some of the factors limiting the growth of the market for needle-free IV connectors. Strict product approval & unfavourable reimbursement policies are also some of the factors impeding sales growth.

• For instance, the United States FDA issued a recall for the CareFusion MaxPlus Clear Needleless Connector in May 2019 from Becton Dickinson & Company due to the connector's loose fit with the luer. The likelihood of loss of blood and the development of air emboli (air bubbles) in blood circulation is predicted to increase with the loose-fitting, particularly in the newborn population.

Country-wise Analysis

What is the Demand Outlook for Needle-free IV Connectors in the United States?

“Growing Rate of Cardiac Cases in the Country”

Improved healthcare infrastructure, the growing rate of the senior population, and higher levels of awareness among healthcare professionals about the benefits of needleless connectors are some of the factors driving needle-free IV connector sales in the United States.

• The most recent statistics from the Centers for Disease Control and Prevention (CDC), which were released in October 2022, show that a heart attack happens in the United States every 40 seconds and that over 805,000 Americans experience a heart attack each year.

This report indicates the rising use of catheters for treatment procedures, which further increases the demand for IV connectors. Thus, rising cases of cardiac disorders are expected to boost sales growth during the forecast period.

How is Germany Faring in the Europe Needle-free IV Connectors Market?

“Rapid Advancements in Drug Delivery Systems”

Sales of needle-free IV connectors in Germany are expected to evolve at a CAGR of 7% from 2023 to 2033. This might be due to the increasing incidences of fatal illnesses, the growing need for needle-free drug administration systems, and the accessibility of cutting-edge drug delivery technologies.

Germany is progressing rapidly in terms of innovation and wellness. The nation's increasing emphasis on R&D and patented drug delivery techniques is driving up demand for needle-free IV connectors. Due to established patient safety guidelines and an increase in needle stick injuries, sales growth is also anticipated to expand significantly over the next ten years.

All of the main pharmaceutical and biotechnology companies are active in Germany. To expand their brand presence, the companies in the needle-free IV connectors market are regularly taking steps to introduce new items.

Why is the Usage of Needle-free IV Connectors High in Japan?

“Noticeably High Prevalence of Diabetes”

The prevalence of diabetes is increasing swiftly in Japan. Innovations in drug delivery technologies and rapid adoption of advanced needless injections are driving sales growth.

Type 2 diabetes is associated with living a sedentary lifestyle, which causes the development of innate resistance to insulin. Type 1 diabetes is brought on by an immune system malfunction. In light of this, Type 1 diabetes can be described as insulin-required diabetes, whereas Type 2 diabetes can be described as insulin-dependent diabetes.

With one of the world's major geriatric populations, Japan has a higher risk of developing type 2 diabetes. The cases of diabetes are increasing in Japan with the rapidly growing rate of the ageing population. Global demand for needle-free IV connectors in Japan is predicted to progress at a CAGR of 6% during the next 10 years.

Category-wise Analysis

Who is a Major End User of Needle-free IV Connectors?

“Hospitals Account for Bulk of Needle-free IV Connector Sales”

Patients prefer hospitals as a primary choice for treatment procedures due to the presence of advanced healthcare infrastructure and skilled medical experts. Nurse stations, operating rooms, emergency rooms, and outpatient centers all need a significant supply of needle-free injectors on hand. The purchase of needless injectors is often done through an open tender by hospitals.

Over the forecast period, the rising rate of hospitals around the world and the increasing rate of patients being admitted to hospitals are both anticipated to fuel sales growth.

Competitive Landscape

According to Fact.MR, a market research and competitive intelligence provider, the key players in the needle-free IV connectors market are adopting various marketing tactics such as mergers, acquisitions, new product developments & innovations, and more. To earn more and maintain their market position they are also focusing on local supply strategies such as partnerships with local suppliers, changing pricing trends based on regional demand for products, and technological advancements.

• The CARESITE needleless connectors from B Braun are positive displacement devices that are intended to lessen catheter occlusions while shielding healthcare workers from unintentional needle sticks.

Needle-free IV Connectors Industry Research Segmentation

• By Type :

  • Positive Fluid Displacement Connectors
  • Negative Fluid Displacement Connectors
  • Neutral Fluid Displacement Connectors

• By Design :

  • Straight Channel
  • T-channel
  • Y-channel
  • Multi-channel

• By End User :

  • Hospitals
  • Ambulatory Surgical Centers

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA